vs
ALKAMI TECHNOLOGY, INC.(ALKT)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是ALKAMI TECHNOLOGY, INC.的1.6倍($197.9M vs $126.1M),REPLIGEN CORP净利率更高(6.7% vs -7.9%,领先14.6%),ALKAMI TECHNOLOGY, INC.同比增速更快(28.9% vs 13.6%),REPLIGEN CORP自由现金流更多($17.6M vs $-7.4M),过去两年ALKAMI TECHNOLOGY, INC.的营收复合增速更高(23.9% vs 14.4%)
Alkami科技是一家面向美国市场的云原生数字银行解决方案提供商,主要为社区银行、信用合作社等金融机构提供在线及移动银行系统、支付处理工具、数据分析模块与客户互动功能,助力合作机构优化终端用户的数字银行使用体验。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
ALKT vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.6倍
$126.1M
营收增速更快
ALKT
高出15.3%
13.6%
净利率更高
RGEN
高出14.6%
-7.9%
自由现金流更多
RGEN
多$24.9M
$-7.4M
两年增速更快
ALKT
近两年复合增速
14.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $126.1M | $197.9M |
| 净利润 | $-10.0M | $13.3M |
| 毛利率 | 58.6% | 52.5% |
| 营业利润率 | 36.9% | 9.0% |
| 净利率 | -7.9% | 6.7% |
| 营收同比 | 28.9% | 13.6% |
| 净利润同比 | -27.5% | 143.9% |
| 每股收益(稀释后) | — | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ALKT
RGEN
| Q1 26 | $126.1M | — | ||
| Q4 25 | $120.8M | $197.9M | ||
| Q3 25 | $113.0M | $188.8M | ||
| Q2 25 | $112.1M | $182.4M | ||
| Q1 25 | $97.8M | $169.2M | ||
| Q4 24 | $89.7M | $174.1M | ||
| Q3 24 | $85.9M | $154.9M | ||
| Q2 24 | $82.2M | $154.1M |
净利润
ALKT
RGEN
| Q1 26 | $-10.0M | — | ||
| Q4 25 | — | $13.3M | ||
| Q3 25 | $-14.8M | $14.9M | ||
| Q2 25 | $-13.6M | $14.9M | ||
| Q1 25 | — | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $-9.4M | $-654.0K | ||
| Q2 24 | $-12.3M | $3.3M |
毛利率
ALKT
RGEN
| Q1 26 | 58.6% | — | ||
| Q4 25 | 57.2% | 52.5% | ||
| Q3 25 | 56.8% | 53.2% | ||
| Q2 25 | 58.6% | 50.0% | ||
| Q1 25 | 59.0% | 53.6% | ||
| Q4 24 | 59.3% | 26.1% | ||
| Q3 24 | 58.9% | 50.0% | ||
| Q2 24 | 59.4% | 49.8% |
营业利润率
ALKT
RGEN
| Q1 26 | 36.9% | — | ||
| Q4 25 | -7.9% | 9.0% | ||
| Q3 25 | -11.4% | 8.9% | ||
| Q2 25 | -14.2% | 7.6% | ||
| Q1 25 | -15.7% | 3.9% | ||
| Q4 24 | -9.6% | -17.7% | ||
| Q3 24 | -12.1% | -5.1% | ||
| Q2 24 | -16.1% | 1.0% |
净利率
ALKT
RGEN
| Q1 26 | -7.9% | — | ||
| Q4 25 | — | 6.7% | ||
| Q3 25 | -13.1% | 7.9% | ||
| Q2 25 | -12.1% | 8.2% | ||
| Q1 25 | — | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | -11.0% | -0.4% | ||
| Q2 24 | -15.0% | 2.2% |
每股收益(稀释后)
ALKT
RGEN
| Q1 26 | — | — | ||
| Q4 25 | $-0.11 | $0.24 | ||
| Q3 25 | $-0.14 | $0.26 | ||
| Q2 25 | $-0.13 | $0.26 | ||
| Q1 25 | $-0.08 | $0.10 | ||
| Q4 24 | $-0.07 | $-0.55 | ||
| Q3 24 | $-0.09 | $-0.01 | ||
| Q2 24 | $-0.13 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $40.4M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $370.7M | $2.1B |
| 总资产 | $829.3M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
ALKT
RGEN
| Q1 26 | $40.4M | — | ||
| Q4 25 | $63.5M | $767.6M | ||
| Q3 25 | $57.3M | $748.7M | ||
| Q2 25 | $52.4M | $708.9M | ||
| Q1 25 | $61.7M | $697.2M | ||
| Q4 24 | $94.4M | $757.4M | ||
| Q3 24 | $81.0M | $784.0M | ||
| Q2 24 | $61.4M | $809.1M |
总债务
ALKT
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益
ALKT
RGEN
| Q1 26 | $370.7M | — | ||
| Q4 25 | $362.0M | $2.1B | ||
| Q3 25 | $350.1M | $2.1B | ||
| Q2 25 | $344.0M | $2.1B | ||
| Q1 25 | $334.0M | $2.0B | ||
| Q4 24 | $357.0M | $2.0B | ||
| Q3 24 | $338.5M | $2.0B | ||
| Q2 24 | $327.2M | $2.0B |
总资产
ALKT
RGEN
| Q1 26 | $829.3M | — | ||
| Q4 25 | $847.2M | $2.9B | ||
| Q3 25 | $835.2M | $2.9B | ||
| Q2 25 | $840.4M | $2.9B | ||
| Q1 25 | $837.2M | $2.9B | ||
| Q4 24 | $437.3M | $2.8B | ||
| Q3 24 | $422.2M | $2.8B | ||
| Q2 24 | $403.9M | $2.9B |
负债/权益比
ALKT
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-4.8M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-7.4M | $17.6M |
| 自由现金流率自由现金流/营收 | -5.8% | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $40.1M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
ALKT
RGEN
| Q1 26 | $-4.8M | — | ||
| Q4 25 | $16.6M | $25.7M | ||
| Q3 25 | $30.8M | $48.1M | ||
| Q2 25 | $1.2M | $28.6M | ||
| Q1 25 | $-5.7M | $15.0M | ||
| Q4 24 | $6.1M | $39.2M | ||
| Q3 24 | $11.0M | $49.3M | ||
| Q2 24 | $548.0K | $42.2M |
自由现金流
ALKT
RGEN
| Q1 26 | $-7.4M | — | ||
| Q4 25 | $16.2M | $17.6M | ||
| Q3 25 | $30.5M | $43.4M | ||
| Q2 25 | $760.0K | $21.5M | ||
| Q1 25 | $-6.1M | $11.4M | ||
| Q4 24 | $6.0M | $33.6M | ||
| Q3 24 | $10.7M | $42.3M | ||
| Q2 24 | $123.0K | $37.4M |
自由现金流率
ALKT
RGEN
| Q1 26 | -5.8% | — | ||
| Q4 25 | 13.4% | 8.9% | ||
| Q3 25 | 27.0% | 23.0% | ||
| Q2 25 | 0.7% | 11.8% | ||
| Q1 25 | -6.3% | 6.8% | ||
| Q4 24 | 6.6% | 19.3% | ||
| Q3 24 | 12.4% | 27.3% | ||
| Q2 24 | 0.1% | 24.3% |
资本支出强度
ALKT
RGEN
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 4.1% | ||
| Q3 25 | 0.2% | 2.5% | ||
| Q2 25 | 0.4% | 3.9% | ||
| Q1 25 | 0.5% | 2.1% | ||
| Q4 24 | 0.2% | 3.2% | ||
| Q3 24 | 0.4% | 4.5% | ||
| Q2 24 | 0.5% | 3.1% |
现金转化率
ALKT
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图